Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7858118 | CIPHER PHARMS INC | Extended release composition containing Tramadol |
Apr, 2022
(1 year, 1 month ago) |
Market Authorisation Date: 07 May, 2010
Treatment: Use of tramadol for the management of moderate to moderately severe chronic pain
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
6
United States
1
Canada
1
Australia
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US11103452 | ATHENA | Tramadol hydrochloride solution |
Sep, 2040
(17 years from now) |
Market Authorisation Date: 01 September, 2020
Treatment: Management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate
Dosage: SOLUTION;ORAL
4
United States
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7988998 | PURDUE PHARMA | Sustained-release tramadol formulations with 24-hour efficacy |
Oct, 2023
(4 months from now) |
Market Authorisation Date: 30 December, 2008
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
8
United States
5
Canada
3
Brazil
3
Japan
2
Spain
2
Austria
2
Hong Kong
2
Denmark
2
Germany
2
Russia
2
China
2
Ukraine
2
Argentina
2
Norway
2
New Zealand
2
Korea, Republic of
2
Israel
2
Portugal
2
Taiwan
2
Mexico
2
Australia
2
Ecuador
2
South Africa
2
Slovenia
2
European Union
1
Malaysia
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic